Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study

NCT00630227 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aeris Therapeutics